Affordable Access

Access to the full text

Mutation spectrum of EXT1 and EXT2 in the Saudi patients with hereditary multiple exostoses

Authors
  • Al-Zayed, Zayed1, 2
  • Al-Rijjal, Roua A.3
  • Al-Ghofaili, Lamya2
  • BinEssa, Huda A.3
  • Pant, Rajeev1
  • Alrabiah, Anwar1, 2
  • Al-Hussainan, Thamer1, 2
  • Zou, Minjing3
  • Meyer, Brian F.3
  • Shi, Yufei3
  • 1 King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia , Riyadh (Saudi Arabia)
  • 2 Alfaisal University, Riyadh, Saudi Arabia , Riyadh (Saudi Arabia)
  • 3 King Faisal Specialist Hospital and Research Center, Riyadh, 11211, Saudi Arabia , Riyadh (Saudi Arabia)
Type
Published Article
Journal
Orphanet Journal of Rare Diseases
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Feb 25, 2021
Volume
16
Issue
1
Identifiers
DOI: 10.1186/s13023-021-01738-z
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundHereditary Multiple Exostoses (HME), also known as Multiple Osteochondromas (MO) is a rare genetic disorder characterized by multiple benign cartilaginous bone tumors, which are caused by mutations in the genes for exostosin glycosyltransferase 1 (EXT1) and exostosin glycosyltransferase 2 (EXT2). The genetic defects have not been studied in the Saudi patients.Aim of studyWe investigated mutation spectrum of EXT1 and EXT2 in 22 patients from 17 unrelated families.MethodsGenomic DNA was extracted from peripheral leucocytes. The coding regions and intron–exon boundaries of both EXT1 and EXT2 genes were screened for mutations by PCR-sequencing analysis. Gross deletions were analyzed by MLPA analysis.ResultsEXT1 mutations were detected in 6 families (35%) and 3 were novel mutations: c.739G > T (p. E247*), c.1319delG (p.R440Lfs*4), and c.1786delA (p.S596Afs*25). EXT2 mutations were detected in 7 families (41%) and 3 were novel mutations: c.541delG (p.D181Ifs*89), c.583delG (p.G195Vfs*75), and a gross deletion of approximately 10 kb including promoter and exon 1. Five patients from different families had no family history and carried de novo mutations (29%, 5/17). No EXT1 and EXT2 mutations were found in the remaining four families. In total, EXT1 and EXT2 mutations were found in 77% (13/17) of Saudi HME patients.ConclusionEXT1 and EXT2 mutations contribute significantly to the pathogenesis of HME in the Saudi population. In contrast to high mutation rate in EXT 1 (65%) and low mutation rate in EXT2 (25%) in other populations, the frequency of EXT2 mutations are much higher (41%) and comparable to that of EXT1 among Saudi patients. De novo mutations are also common and the six novel EXT1/EXT2 mutations further expands the mutation spectrum of HME.

Report this publication

Statistics

Seen <100 times